Effect of pharmacogenetics on medicine.
- 12 April 2001
- journal article
- review article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 37 (3), 179-184
- https://doi.org/10.1002/em.1026
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Elucidation of the genetic basis of the common ‘intermediate metabolizer’ phenotype for drug oxidation by CYP2D6Pharmacogenetics, 2000
- Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessProceedings of the National Academy of Sciences, 2000
- The superfamily of heptahelical receptorsNature, 2000
- Advances in Understanding Drug Metabolism and Its Contribution to Variability in Patient ResponseTherapeutic Drug Monitoring, 2000
- Clinical, genetic, and pharmacogenetic applications of the invader assayMolecular Diagnosis, 1999
- Potassium ion channels and human disease: phenotypes to drug targets?Current Opinion in Biotechnology, 1998
- DNA variation and the future of human geneticsNature Biotechnology, 1998
- Validation of the five-drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes*Cancer Cell, 1997
- Regulation of Cytochromes P450 During Inflammation and InfectionDrug Metabolism Reviews, 1997
- The rise and fall of positional cloning?Nature Genetics, 1993